Atai Life Sciences Shares Outstanding 2020-2023 | ATAI

Atai Life Sciences shares outstanding from 2020 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Atai Life Sciences Annual Shares Outstanding
(Millions of Shares)
2023 159
2022 156
2021 138
2020 93
2019 87
Atai Life Sciences Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 159
2023-09-30 178
2023-06-30 156
2023-03-31 156
2022-12-31 156
2022-09-30 157
2022-06-30 154
2022-03-31 154
2021-12-31 138
2021-09-30 151
2021-06-30 132
2021-03-31 121
2020-12-31 93
2020-09-30 91
2020-06-30 91
2020-03-31 94
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.343B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.269B 10.45
Quest Diagnostics (DGX) United States $15.262B 15.77
DaVita (DVA) United States $11.791B 14.65
Chemed (CHE) United States $8.503B 26.36
Encompass Health (EHC) United States $8.333B 21.45
Elanco Animal Health (ELAN) United States $6.685B 15.20
Option Care Health (OPCH) United States $5.181B 19.61
RadNet (RDNT) United States $3.783B 102.40
Amedisys (AMED) United States $3.009B 21.31
LifeStance Health (LFST) United States $2.546B 0.00
Astrana Health (ASTH) United States $2.099B 26.20
Addus HomeCare (ADUS) United States $1.608B 24.43
U.S Physical Therapy (USPH) United States $1.585B 41.09
Pennant (PNTG) United States $0.642B 37.54
Aveanna Healthcare Holdings (AVAH) United States $0.448B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00